← Previous Post: | Next Post:

 

‘The University will not take action against former Professor of Psychiatry and Human Behavior Martin Keller, despite acknowledgment by pharmaceutical giant GlaxoSmithKline that Keller co-authored a fraudulent study advocating adolescent use of the antidepressant Paxil.’

This first paragraph from today’s Brown University newspaper isn’t quite correct. It should read “co-ghosted.” Because not only did Brown’s Keller put his name on a fraudulent study, he seems to have allowed his good friend Glaxo to write the article for him. “Keller acknowledged in 2006 that over the years, he had received tens of thousands of dollars from GSK and its affiliates.”

Brown University stands in fervent solidarity with Martin Keller.

After all, this sort of corruption is a drop in the bucket for Brown, whose last president signed off on the Goldman Sachs bonuses, and whose board of trustees is a Rappaccini’s garden of shady hedgies.

Brown has grown a certain money culture; in it, special relationships with friends like Glaxo Smith Kline and Goldman Sachs bloom. That’s Brown.

Margaret Soltan, September 14, 2012 11:26AM
Posted in: conflict of interest

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=37332

2 Responses to “‘The University will not take action against former Professor of Psychiatry and Human Behavior Martin Keller, despite acknowledgment by pharmaceutical giant GlaxoSmithKline that Keller co-authored a fraudulent study advocating adolescent use of the antidepressant Paxil.’”

  1. Bernard Carroll Says:

    As I commented on Pharmalot not long ago, a feature of professions is that they regulate themselves. We should not need third parties (Universities, Office of Research Integrity at NIH) to step in here. We know who the academic authors of Study 329 are. We know what professional societies they belong to. We know that these professional societies have codes of ethics that sing of integrity.

    So, now that GSK has admitted criminal fraud in relation to Study 329, where are the leaders of these professional societies in requiring integrity and ethical behavior from their members who (ahem) co-authored the study? A no-brainer would be for the professional societies to require these academic authors to retract the fraudulent report. They could slap on these authors a ban from society activities and a ban on publication in society journals until the retraction occurs. And instead of hiding their heads in the sand, the leaders of these professional societies could issue PR statements to educate the public about our professional values.

    Will any of this happen? Let’s see. They have been put on notice.

    This comment is going up simultaneously on 1boringoldman.com.

  2. Jack/OH Says:

    We’re in a mess of trouble.

Comment on this Entry

Latest UD posts at IHE

Archives

Categories